Trial · NCT04402489
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 26 Weeks Double-Blind Treatment (DBT) | STARTED | Placebo | 61 | |
| 26 Weeks Double-Blind Treatment (DBT) | STARTED | MT-7117 Low Dose | 63 | |
| 26 Weeks Double-Blind Treatment (DBT) | STARTED | MT-7117 High Dose | 60 | |
| 26 Weeks Double-Blind Treatment (DBT) | STARTED | Placebo -> MT-7117 Low Dose | 0 | |
| 26 Weeks Double-Blind Treatment (DBT) | STARTED | Placebo -> MT-7117 High Dose | 0 | |
| 26 Weeks Double-Blind Treatment (DBT) | COMPLETED | Placebo | 57 | |
| 26 Weeks Double-Blind Treatment (DBT) | COMPLETED | MT-7117 Low Dose | 60 | |
| 26 Weeks Double-Blind Treatment (DBT) | COMPLETED | MT-7117 High Dose | 58 | |
| 26 Weeks Double-Blind Treatment (DBT) | COMPLETED | Placebo -> MT-7117 Low Dose | 0 | |
| 26 Weeks Double-Blind Treatment (DBT) | COMPLETED | Placebo -> MT-7117 High Dose | 0 | |
| 26 Weeks Double-Blind Treatment (DBT) | NOT COMPLETED | Placebo | 4 | |
| 26 Weeks Double-Blind Treatment (DBT) | NOT COMPLETED | MT-7117 Low Dose | 3 | |
| 26 Weeks Double-Blind Treatment (DBT) | NOT COMPLETED | MT-7117 High Dose | 2 | |
| 26 Weeks Double-Blind Treatment (DBT) | NOT COMPLETED | Placebo -> MT-7117 Low Dose | 0 | |
| 26 Weeks Double-Blind Treatment (DBT) | NOT COMPLETED | Placebo -> MT-7117 High Dose | 0 | |
| 26 Weeks Double-Blind Extension (DBE) | STARTED | Placebo | 0 | |
| 26 Weeks Double-Blind Extension (DBE) | STARTED | MT-7117 Low Dose | 56 | |
| 26 Weeks Double-Blind Extension (DBE) | STARTED | MT-7117 High Dose | 55 | |
| 26 Weeks Double-Blind Extension (DBE) | STARTED | Placebo -> MT-7117 Low Dose | 28 | |
| 26 Weeks Double-Blind Extension (DBE) | STARTED | Placebo -> MT-7117 High Dose | 28 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04402489/flow